TLNRD1 is a CCM complex component and regulates endothelial barrier integrity.
Humans
Animals
Hemangioma, Cavernous, Central Nervous System
/ metabolism
Human Umbilical Vein Endothelial Cells
/ metabolism
Endothelial Cells
/ metabolism
Focal Adhesions
/ metabolism
Carrier Proteins
/ metabolism
Stress Fibers
/ metabolism
Actins
/ metabolism
Actin Cytoskeleton
/ metabolism
Protein Binding
Mice
Cell Nucleus
/ metabolism
Talin
Journal
The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356
Informations de publication
Date de publication:
02 Sep 2024
02 Sep 2024
Historique:
received:
06
10
2023
revised:
08
04
2024
accepted:
23
05
2024
medline:
17
7
2024
pubmed:
17
7
2024
entrez:
16
7
2024
Statut:
ppublish
Résumé
We previously identified talin rod domain-containing protein 1 (TLNRD1) as a potent actin-bundling protein in vitro. Here, we report that TLNRD1 is expressed in the vasculature in vivo. Its depletion leads to vascular abnormalities in vivo and modulation of endothelial cell monolayer integrity in vitro. We demonstrate that TLNRD1 is a component of the cerebral cavernous malformations (CCM) complex through its direct interaction with CCM2, which is mediated by a hydrophobic C-terminal helix in CCM2 that attaches to a hydrophobic groove on the four-helix domain of TLNRD1. Disruption of this binding interface leads to CCM2 and TLNRD1 accumulation in the nucleus and actin fibers. Our findings indicate that CCM2 controls TLNRD1 localization to the cytoplasm and inhibits its actin-bundling activity and that the CCM2-TLNRD1 interaction impacts endothelial actin stress fiber and focal adhesion formation. Based on these results, we propose a new pathway by which the CCM complex modulates the actin cytoskeleton and vascular integrity.
Identifiants
pubmed: 39013281
pii: 276861
doi: 10.1083/jcb.202310030
pii:
doi:
Substances chimiques
CCM2 protein, human
0
TLN1 protein, human
0
Carrier Proteins
0
Actins
0
Talin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Biocenter Finland
Organisme : Research Council of Finland
ID : 338537
Organisme : Sigrid Juselius Foundation
Organisme : Cancer Society of Finland
Organisme : Åbo Akademi University
Organisme : Academy of Finland
ID : 337530
Organisme : Finnish Cancer Institute
Organisme : Centre of Excellence
ID : # 346131
Organisme : Jane and Aatos Erkko Foundation
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S007245/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CRUK-A21671
Pays : United Kingdom
Informations de copyright
© 2024 Ball et al.